AMFR antibody (AA 384-643)

Catalog No. ABIN1678650

This anti-AMFR antibody is a Rabbit Polyclonal antibody detecting AMFR in WB. Suitable for Human.

Quick Overview for AMFR antibody (AA 384-643) (ABIN1678650)

Target: AMFR (Autocrine Motility Factor Receptor (AMFR))

Reactivity: Human

Host: Rabbit

Clonality: Polyclonal

Conjugate: This AMFR antibody is un-conjugated

Application: Western Blotting (WB)

Product Details anti-AMFR Antibody

Binding Specificity: AA 384-643

Sequence: IADNNRVREE HQGENLDENL VPVAAAEGRP RLNQHNHFFH FDGSRIASWL PSFSVEVMHT TNILGITQAS NSQLNAMAHQ IQEMFPQVPY HLVLQDLQLT RSVEITTDNI LEGRIQVPFP TQRSDSIRPA LNSPVERPSS DQEEGETSAQ TERVPLDLSP RLEETLDFGE VEVEPSEVED FEARGSRFSK SADERQRMLV QRKDELLQQA RKRFLNKSSE DDAASESFLP SEGASSDPVT LRRRMLAAAA ERRLQKQQTS

Cross-Reactivity: Human

Characteristics: Polyclonal Antibodies

Purification: Affinity purification

Immunogen: Recombinant fusion protein containing a sequence corresponding to amino acids 384-643 of human AMFR (NP_001135.3).

Isotype: IgG

Application Details

Application Notes: WB,1:500 - 1:2000

Restrictions: For Research Use only

Handling

Buffer: PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.

Preservative: Sodium azide

Precaution of Use: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: -20 °C

Storage Comment: Store at -20°C. Avoid freeze / thaw cycles.

Target Details for AMFR

Target: AMFR (Autocrine Motility Factor Receptor (AMFR))

Alternative Name: AMFR

Background: This locus encodes a glycosylated transmembrane receptor. Its ligand, autocrine motility factor, is a tumor motility-stimulating protein secreted by tumor cells. The encoded receptor is also a member of the E3 ubiquitin ligase family of proteins. It catalyzes ubiquitination and endoplasmic reticulum-associated degradation of specific proteins.,AMFR,GP78,RNF45,Cancer,Tumor biomarkers,Cell Biology & Developmental Biology,Ubiquitin,AMFR

Molecular Weight: 72 kDa

Gene ID: 267

UniProt: Q9UKV5

Pathways: ER-Nucleus Signaling